Bernard Mouillac

Centre National de la Recherche Scientifique — France

Psychology · Social Sciences

43h-index7.4kcitations147works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroendocrine regulation and behavior(83), Receptor Mechanisms and Signaling(78), Neuropeptides and Animal Physiology(30), Neuroscience of respiration and sleep(19), Electrolyte and hormonal disorders(17)

Publications145 total

TR-FRET between engineered nanobodies reveals the existence of endogenous CXCR4 oligomers
Communications Biology·2025Open Access
Inactive structures of the vasopressin V2 receptor reveal distinct binding modes for Tolvaptan and Mambaquaretin toxin
Nature Communications·2025· 3 citedOpen Access
G protein peptidomimetics reveal allosteric effects and stepwise interactions in ghrelin receptor–G protein coupling
Science Signaling·2025· 2 citedOpen Access
Cover Image
Journal of the American Society of Nephrology·2025
Inactive structures of the vasopressin V2 receptor reveal distinct antagonist binding modes for Tolvaptan and Mambaquaretin toxin
2024· 1 citedOpen Access
Biased activation of the vasopressin V2 receptor probed by molecular dynamics simulations, NMR and pharmacological studies
Computational and Structural Biotechnology Journal·2024· 4 citedOpen Access
A Snake Toxin Derivative for Treatment of Hyponatremia and Polycystic Kidney Diseases
Journal of the American Society of Nephrology·2024Open Access
Structural characterization of the active and inactive conformations of the vasopressin V2 receptor using cryo-EM
BIO Web of Conferences·2024Open Access
Bringing GPCR Structural Biology to Medical Applications: Insights from Both V2 Vasopressin and Mu-Opioid Receptors
Membranes·2023· 4 citedOpen Access
Biased activation of the vasopressin V2 receptor probed by NMR, paramagnetic ligands, and molecular dynamics simulations
2023· 2 citedOpen Access
Vasopressin and oxytocin receptors in GtoPdb v.2023.1
IUPHAR/BPS Guide to Pharmacology CITE·2023· 2 citedOpen Access
Structures of the arginine-vasopressin and oxytocin receptor signaling complexes
Vitamins and hormones·2023· 10 cited
Structure of the vasopressin hormone–V2 receptor–β-arrestin1 ternary complex
Science Advances·2022· 114 citedOpen Access
Structure of the vasopressin hormone-V2 receptor-β-arrestin1 ternary complex
2022· 5 citedOpen Access
A new Kunitz‐type snake toxin family associated with an original mode of interaction with the vasopressin 2 receptor
British Journal of Pharmacology·2022· 17 citedOpen Access
Functional Rescue of a Nephrogenic Diabetes Insipidus Causing Mutation in the V2 Vasopressin Receptor by Specific Antagonist and Agonist Pharmacochaperones
Frontiers in Pharmacology·2022· 15 citedOpen Access
Carbohydrate-Based NK1R Antagonists with Broad-Spectrum Anticancer Activity
Journal of Medicinal Chemistry·2021· 21 citedOpen Access
A new Kunitz-type snake toxin family associated with an original mode of interaction with the vasopressin 2 receptor.
2021· 1 citedOpen Access
Cryo–electron microscopy structure of the antidiuretic hormone arginine-vasopressin V2 receptor signaling complex
Science Advances·2021· 41 citedOpen Access
The ligand-bound state of a G protein-coupled receptor stabilizes the interaction of functional cholesterol molecules
Journal of Lipid Research·2021· 22 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Thierry Durroux(19), Claude Barberis(17), Marcel Hibert(14), Marie‐Noëlle Balestre(11), Gilles Guillon(9), Hélène Orcel(8), Maurice Manning(7), Christiane Mendre(7), Bice Chini(6), René Seyer(6), Christophe Breton(6), Michel Bouvier(6), Serge Jard(6), Jean‐Louis Banères(6), Sébastien Granier(6), Nathalie de la Cotte(6), M. Manning(5), Martin Cottet(5), Eric Trinquet(5), Rita Rahmeh(5)